Twist Bioscience Corporation operates as a biotechnology company. The Company specializes in synthetic DNA such as biodetection, functional genomics, genome engineering, drugs and biodefense, and data storage. Twist Bioscience serves patients in the United States.

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Annual Report (Form 10-K | Period ending 2024-09-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Twist Bioscience (TWST US)

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Annual Report (Form 10-K | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-11-18)

Current Report (Form 8-K | Period ending 2024-10-08)

Quarterly Report (Form 10-Q | Period ending 2024-06-30)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)